Translocation of PEGylated quantum dots across rat alveolar epithelial cell monolayers

Background In this study, primary rat alveolar epithelial cell monolayers (RAECM) were used to investigate transalveolar epithelial quantum dot trafficking rates and underlying transport mechanisms. Methods Trafficking rates of quantum dots (PEGylated CdSe/ZnS, core size 5.3 nm, hydrodynamic size 25 nm) in the apical-to-basolateral direction across RAECM were determined. Changes in bioelectric properties (ie, transmonolayer resistance and equivalent active ion transport rate) of RAECM in the presence or absence of quantum dots were measured. Involvement of endocytic pathways in quantum dot trafficking across RAECM was assessed using specific inhibitors (eg, methyl-β-cyclodextrin, chlorpromazine, and dynasore for caveolin-, clathrin-, and dynamin-mediated endocytosis, respectively). The effects of lowering tight junctional resistance on quantum dot trafficking were determined by depleting Ca2+ in apical and basolateral bathing fluids of RAECM using 2 mM EGTA. Effects of temperature on quantum dot trafficking were studied by lowering temperature from 37°C to 4°C. Results Apical exposure of RAECM to quantum dots did not elicit changes in transmonolayer resistance or ion transport rate for up to 24 hours; quantum dot trafficking rates were not surface charge-dependent; methyl-β-cyclodextrin, chlorpromazine, and dynasore did not decrease quantum dot trafficking rates; lowering of temperature decreased transmonolayer resistance by approximately 90% with a concomitant increase in quantum dot trafficking by about 80%; and 24 hours of treatment of RAECM with EGTA decreased transmonolayer resistance by about 95%, with increased quantum dot trafficking of up to approximately 130%. Conclusion These data indicate that quantum dots do not injure RAECM and that quantum dot trafficking does not appear to take place via endocytic pathways involving caveolin, clathrin, or dynamin. We conclude that quantum dot translocation across RAECM takes place via both transcellular and paracellular pathways and, based on comparison with our prior studies, interactions of nanoparticles with RAECM are strongly dependent on nanoparticle composition and surface properties.

[1]  A. Yu,et al.  Polystyrene nanoparticle trafficking across MDCK-II. , 2011, Nanomedicine : nanotechnology, biology, and medicine.

[2]  Mark Green,et al.  Some aspects of quantum dot toxicity. , 2011, Chemical communications.

[3]  Thierry Bastogne,et al.  Quantum dot-folic acid conjugates as potential photosensitizers in photodynamic therapy of cancer , 2011, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[4]  Hong Ding,et al.  Doxorubicin-conjugated quantum dots to target alveolar macrophages and inflammation. , 2011, Nanomedicine : nanotechnology, biology, and medicine.

[5]  Lutz Mädler,et al.  Decreased dissolution of ZnO by iron doping yields nanoparticles with reduced toxicity in the rodent lung and zebrafish embryos. , 2011, ACS nano.

[6]  I. Kennedy,et al.  Alveolar epithelial cell injury due to zinc oxide nanoparticle exposure. , 2010, American journal of respiratory and critical care medicine.

[7]  K. Sheng,et al.  Tumor cell apoptosis induced by nanoparticle conjugate in combination with radiation therapy , 2010, Nanotechnology.

[8]  S. Gambhir,et al.  Facile synthesis, silanization, and biodistribution of biocompatible quantum dots. , 2010, Small.

[9]  Noah Malmstadt,et al.  Mechanisms of alveolar epithelial translocation of a defined population of nanoparticles. , 2010, American journal of respiratory cell and molecular biology.

[10]  M. Chu,et al.  A novel method for preparing quantum dot nanospheres with narrow size distribution. , 2010, Nanoscale.

[11]  B. Nemery,et al.  In vitro translocation of quantum dots and influence of oxidative stress. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[12]  Younes Ghasemi,et al.  Quantum dot: magic nanoparticle for imaging, detection and targeting. , 2009, Acta bio-medica : Atenei Parmensis.

[13]  Nancy A Monteiro-Riviere,et al.  Mechanisms of quantum dot nanoparticle cellular uptake. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[14]  M Laird Forrest,et al.  Effects of nanomaterial physicochemical properties on in vivo toxicity. , 2009, Advanced drug delivery reviews.

[15]  H. McMahon,et al.  Mechanisms of endocytosis. , 2009, Annual review of biochemistry.

[16]  Brad A. Kairdolf,et al.  Proton-resistant quantum dots: Stability in gastrointestinal fluids and implications for oral delivery of nanoparticle agents , 2009, Nano research.

[17]  M. Olivo,et al.  Critical parameters in the pegylation of gold nanoshells for biomedical applications: An in vitro macrophage study , 2009, Journal of drug targeting.

[18]  V. Josserand,et al.  Effect of poly(ethylene glycol) length on the in vivo behavior of coated quantum dots. , 2009, Langmuir : the ACS journal of surfaces and colloids.

[19]  K. Landfester,et al.  Uptake mechanism of oppositely charged fluorescent nanoparticles in HeLa cells. , 2008, Macromolecular bioscience.

[20]  Karolin F Meyer,et al.  Quantum dot-carrier peptide conjugates suitable for imaging and delivery applications. , 2008, Bioconjugate chemistry.

[21]  B. Nemery,et al.  Acute Toxicity and Prothrombotic Effects of Quantum Dots: Impact of Surface Charge , 2008, Environmental health perspectives.

[22]  S. Hamm-Alvarez,et al.  Polystyrene nanoparticle trafficking across alveolar epithelium. , 2008, Nanomedicine : nanotechnology, biology, and medicine.

[23]  W. D. de Jong,et al.  Drug delivery and nanoparticles: Applications and hazards , 2008, International journal of nanomedicine.

[24]  Robert Sinclair,et al.  Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice. , 2008, Small.

[25]  Feng Zhao,et al.  The translocation of fullerenic nanoparticles into lysosome via the pathway of clathrin-mediated endocytosis , 2008, Nanotechnology.

[26]  Simon Benita,et al.  Surface charge of nanoparticles determines their endocytic and transcytotic pathway in polarized MDCK cells. , 2008, Biomacromolecules.

[27]  Sanjiv S Gambhir,et al.  microPET-Based Biodistribution of Quantum Dots in Living Mice , 2007, Journal of Nuclear Medicine.

[28]  Sailing He,et al.  Imaging pancreatic cancer using surface-functionalized quantum dots. , 2007, The journal of physical chemistry. B.

[29]  Simon Benita,et al.  Targeting of nanoparticles to the clathrin-mediated endocytic pathway. , 2007, Biochemical and biophysical research communications.

[30]  Takuro Niidome,et al.  PEG-modified gold nanorods with a stealth character for in vivo applications. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[31]  Jean-Pierre Benoit,et al.  Parameters influencing the stealthiness of colloidal drug delivery systems. , 2006, Biomaterials.

[32]  Y. Schneider,et al.  Deoxynivalenol transport across human intestinal Caco-2 cells and its effects on cellular metabolism at realistic intestinal concentrations. , 2006, Toxicology letters.

[33]  T. Kirchhausen,et al.  Dynasore, a cell-permeable inhibitor of dynamin. , 2006, Developmental cell.

[34]  Wei Lai,et al.  Thermo-oxidative degradation of poly(ethylene glycol)/poly(l-lactic acid) blends , 2003 .

[35]  R. Parton,et al.  Lipid Rafts and Caveolae as Portals for Endocytosis: New Insights and Common Mechanisms , 2003, Traffic.

[36]  Ivan R. Nabi,et al.  Caveolae/raft-dependent endocytosis , 2003, The Journal of cell biology.

[37]  B. Qualmann,et al.  Regulation of endocytic traffic by Rho GTPases. , 2003, The Biochemical journal.

[38]  M. Matthay,et al.  Alveolar epithelial transport. Basic science to clinical medicine. , 2001, American journal of respiratory and critical care medicine.

[39]  R T Borchardt,et al.  Paracellular diffusion in Caco-2 cell monolayers: effect of perturbation on the transport of hydrophilic compounds that vary in charge and size. , 1997, Journal of pharmaceutical sciences.

[40]  E. Crandall,et al.  Size-dependent dextran transport across rat alveolar epithelial cell monolayers. , 1997, Journal of pharmaceutical sciences.

[41]  B. Hirst,et al.  Paracellular barrier and junctional protein distribution depend on basolateral extracellular Ca2+ in cultured epithelia. , 1994, Biochimica et biophysica acta.

[42]  Z. Borok,et al.  Defined medium for primary culture de novo of adult rat alveolar epithelial cells , 1994, In Vitro Cellular & Developmental Biology - Animal.

[43]  R. G. Anderson,et al.  Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation , 1993, The Journal of cell biology.

[44]  E. Crandall,et al.  Reactivity of alveolar epithelial cells in primary culture with type I cell monoclonal antibodies. , 1992, American journal of respiratory cell and molecular biology.

[45]  P. Sansonetti,et al.  Shigella flexneri enters human colonic Caco-2 epithelial cells through the basolateral pole , 1992, Infection and immunity.

[46]  J. M. Cheek,et al.  Type I cell-like morphology in tight alveolar epithelial monolayers. , 1989, Experimental cell research.

[47]  J. M. Cheek,et al.  Tight monolayers of rat alveolar epithelial cells: bioelectric properties and active sodium transport. , 1989, The American journal of physiology.

[48]  E R Weibel,et al.  Morphometry of the human pulmonary acinus , 1988, The Anatomical record.

[49]  B. Corrin.  Phagocytic potential of pulmonary alveolar epithelium with particular reference to surfactant metabolism , 1970, Thorax.

[50]  Chee-Youb Won,et al.  PEG-modified biopharmaceuticals. , 2009, Expert opinion on drug delivery.

[51]  H. Tseng,et al.  A supramolecular approach for preparation of size-controlled nanoparticles. , 2009, Angewandte Chemie.

[52]  A. Ivanov,et al.  Pharmacological inhibition of endocytic pathways: is it specific enough to be useful? , 2008, Methods in molecular biology.

[53]  T. Kirchhausen,et al.  Use of dynasore, the small molecule inhibitor of dynamin, in the regulation of endocytosis. , 2008, Methods in enzymology.

[54]  Z. Borok,et al.  Rat serum inhibits progression of alveolar epithelial cells toward the type I cell phenotype in vitro. , 1995, American journal of respiratory cell and molecular biology.

[55]  E. Crandall,et al.  Heteropore populations of bullfrog alveolar epithelium. , 1983, Journal of applied physiology: respiratory, environmental and exercise physiology.

[56]  Chia-Chi Wang,et al.  International Journal of Nanomedicine , 2022 .